𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Labetalol, a cross-over double blind controlled trial

✍ Scribed by G. L. Sanders; P. A. Routledge; J. G. Rao; G. M. Gales; D. M. Davies; M. D. Rawlins

Book ID
104837977
Publisher
Springer
Year
1978
Tongue
English
Weight
410 KB
Volume
14
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A double-blind, placebo-controlled trial
A double-blind, placebo-controlled trial
✍ Robert S. Pinals; Stanley B. Kaplan; Jeffrey G. Lawson; Bonnie Hepburn πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 English βš– 663 KB
Intravenous flumazenil for Parkinson's d
Intravenous flumazenil for Parkinson's disease: A single dose, double blind, placebo controlled, cross-over trial
✍ William G. Ondo; Yavuz S. Silay πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 81 KB πŸ‘ 1 views

## Abstract Flumazenil is a short‐acting intravenously administered γ‐aminobutyric acid (GABA) antagonist used to reverse the effects of benzodiazepines. Based upon current basal ganglion models in Parkinson's disease (PD), flumazenil could normalize neuronal signaling at several different location